Biomega (Norway) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

  • Investments
  • 2

Biomega (Norway) General Information

Description

Producer of salmon oil, salmon meal and hydrolysed salmon proteins intended for the health and nutrition industry. The company's human-grade peptones, proteins and oils derived from fresh fish by-products are delivered as pet food ingredients, nutritional supplements and industrial bioactive components, enabling consumers to avail fresh raw materials.

Contact Information

Website
www.biomegagroup.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Kong Christians Frederiks plass 5
  • 5006 Bergen
  • Norway
+47 55
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Kong Christians Frederiks plass 5
  • 5006 Bergen
  • Norway
+47 55

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomega (Norway) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomega (Norway)‘s full profile, request access.

Request a free trial

Biomega (Norway) Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Biomega (Norway) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201807246-D0 Enzymatic method Inactive 02-May-2018
EP-3788160-A1 Enzymatic method Pending 02-May-2018

Biomega (Norway) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomega (Norway) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomega (Norway)‘s full profile, request access.

Request a free trial

Biomega (Norway) Investments (2)

Biomega (Norway)’s most recent deal was a Buyout/LBO with Atlantic Garden. The deal was made on 02-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Atlantic Garden 02-Aug-2017 Buyout/LBO Pharmaceuticals
Alkymar 10-Mar-2017 Buyout/LBO Other Commercial Services
To view Biomega (Norway)’s complete investments history, request access »

Biomega (Norway) FAQs

  • When was Biomega (Norway) founded?

    Biomega (Norway) was founded in 2000.

  • Where is Biomega (Norway) headquartered?

    Biomega (Norway) is headquartered in Bergen, Norway.

  • What is the size of Biomega (Norway)?

    Biomega (Norway) has 60 total employees.

  • What industry is Biomega (Norway) in?

    Biomega (Norway)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Biomega (Norway) a private or public company?

    Biomega (Norway) is a Private company.

  • What is Biomega (Norway)’s current revenue?

    The current revenue for Biomega (Norway) is .

  • How much funding has Biomega (Norway) raised over time?

    Biomega (Norway) has raised $5M.

  • Who are Biomega (Norway)’s investors?

    AMERRA Capital Management has invested in Biomega (Norway).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »